Why the Nicotine Film Category Needs Long-Term Manufacturing Partners

SENO is a nicotine oral thin film manufacturer based in Shenzhen, China, supported by Xin Sino Technology (Shenzhen) Co., Ltd. and focused on supplying international distributors and brand owners. The company operates a 20,000 m² production facility with a 15-person R&D team, and its products are designed for smoke-free, device-free nicotine delivery.

According to Market Research Future, the global nicotine oral dissolvable thin films market was valued at USD 112.34 million in 2024 and is projected to reach USD 174.18 million by 2035. In a broader context, Grand View Research estimates that the modern oral nicotine products market, including pouches and films, could reach USD 38.9 billion by 2033, growing at a 19.0% CAGR. These figures point to a category that is still small but expanding, which is one reason why procurement decisions are shifting from spot purchases toward structured supplier relationships.

The Procurement Challenge for Distributors and Brand Owners

For distributors, nicotine film is not a conventional commodity. It requires precise dosage control, stable dissolution performance, moisture-resistant packaging, and regulatory alignment with each destination market. Any gap in these areas can create product liability, compliance, or customer experience problems.

Oral thin films are sensitive to humidity and temperature, so storage and packaging integrity become purchasing criteria, not afterthoughts. At the same time, regulators in the EU, US, and other markets are increasing scrutiny of nicotine products, making it harder for distributors to rely on suppliers without documented testing and traceability.

The opportunity for brand owners is that nicotine films can be produced under private labels. A distributor can sell SENO nicotine oral strips or SENO nicotine oral films under its own brand if the manufacturer has OEM and ODM capabilities, which is becoming a key requirement for distributors that want portfolio differentiation.

SENO as a Long-Term Supply Partner

SENO provides OEM, ODM, and private label manufacturing services for nicotine film. According to SENO's procurement terms, the monthly production capacity ranges from 1,000,000 to 5,000,000 strips, and the annual output is between 12,000,000 and 50,000,000 strips. Standard production lead time is 20–30 days, while OEM or custom orders require 30–45 days.

For buyers, the minimum order quantity is 100,000 to 300,000 strips per SKU. Payment terms are typically 30% deposit and 70% balance before shipment, with flexible options for long-term partners. SENO offers FOB, CIF, and DDP delivery, with DDP recommended for new partners. The company exports to Europe, the United States, Canada, Australia, and the Middle East, with 100% of its output going to international markets.

After-sales support includes technical support for product and compliance, marketing material support, fast response for quality or logistics issues, and long-term partnership support, according to SENO's customer-facing documentation.

Product specifications at a glance

Procurement and supply terms

How Oral Thin Film Technology Works

Oral nicotine thin films typically use hydrophilic polymers such as HPMC, which can represent 40–50% of the film weight, to dissolve in 15–30 seconds and deliver nicotine through the oral mucosa. This route bypasses first-pass hepatic metabolism, which is one reason why oral films can offer faster onset compared with traditional oral products that must be chewed or held in the mouth.

SENO formulates its nicotine film using pharmaceutical-grade film-forming polymers, high-purity nicotine, food-grade flavoring agents, and stabilizers and excipients. The company's production process is designed around precision formulation and dosing, with mg-level error control per sheet, batch consistency testing, moisture-barrier packaging, and standardized labeling. In the U.S. market, SENO Oral Films are labeled with a 1.5% nicotine concentration, intended to relieve mental fatigue and alleviate withdrawal symptoms, according to the NIH DailyMed database.

According to SENO's risk management documentation, the company addresses five risk categories: cytotoxicity, nicotine dosage variability, accidental ingestion and underage exposure, storage stability related to humidity and temperature, and cross-jurisdictional regulatory compliance. Control measures include in vitro cytotoxicity testing, quantitative IC50 assessment, child-resistant packaging options, and pre-shipment compliance review.

For one product sample tested by the third-party institution Gmicro Testing, the IC50 result was 1549 μg/mL (95% CI: 1319–1820). The test method was conducted in accordance with the Health Canada T-502 standard. SENO also states that batch testing and data traceability, raw material traceability, and an ongoing safety evaluation system are part of its manufacturing process.

Application Scenarios for Nicotine Oral Strips and Films

SENO nicotine oral strips and SENO nicotine oral films are designed for environments where smoking and vaping are restricted. According to SENO's product comparison materials, the film format is smoke-free, device-free, fast-dissolving, and provides precise dosage control. It does not produce combustion or vapor, and it is described as generating up to 90% less odor compared with smoking.

Common use cases include office and indoor environments, travel and commuting, smoke-free zones, and discreet daily use. For industrial buyers, the relevant channels include nicotine alternative product distribution, FMCG distribution, vape and tobacco alternative channels, private label and brand owner programs, and cross-border e-commerce.

A brand owner entering the EU market, for example, could use SENO's OEM/ODM service to configure dosage, flavor, and packaging, then rely on SENO's compliance adjustment support to align the formula and labels with target market regulations and prepare for PMTA/TPD direction where applicable, as described in SENO's risk management documentation.

Market Trends and Supplier Landscape

The nicotine dissolvable film market remains concentrated in specific strengths and formats. According to Market Research Future, the 2 mg strength segment held the largest market share in 2024, targeting moderate to heavy smokers. This suggests that distributors entering the category should be able to offer entry-level strengths first, while keeping the option for higher or customizable strengths.

The broader modern oral nicotine market is projected to grow at a 19.0% CAGR through 2033, according to Grand View Research. In this environment, key global competitors identified in the nicotine dissolvable film space include Nicoccinno Holding AB, Zim Laboratories, and AdhexPharma, according to MRFR. Within this landscape, SENO's stated focus is on OEM/ODM and private label manufacturing, which gives distributors an alternative to single-brand supply agreements.

For the U.S. market, SENO announced through its official release that it was the first nicotine film brand to receive first-round FDA PMTA registration numbers, including PM0010199, PM0010173, and PM0010176, as of September 2025. This is a relevant data point for distributors evaluating regulatory readiness, although PMTA registration numbers should not be read as a substitute for in-country legal review.

Buyers should also be aware that market size definitions vary. Film-only estimates differ from broader modern oral nicotine projections that include pouches, so distributors should compare figures carefully when building a business case.

How SENO Nicotine Film Compares with Traditional Nicotine Products

When compared with cigarettes, vaping devices, and nicotine pouches, oral film has a distinct set of trade-offs. According to SENO's comparison materials, nicotine film delivers nicotine through oral mucosa absorption, produces no combustion or vapor, and provides more consistent dosage than vaping because delivery is not dependent on user inhalation technique.

From a total cost perspective, oral film does not require hardware, charging, or cleaning, and it does not use consumable parts such as coils or cartridges. This can reduce the long-term cost compared with vaping devices, and it creates less waste than disposable vaping products.

One honest limitation is the format's sensitivity to moisture and temperature. Oral films require moisture-barrier packaging and proper storage conditions to maintain stability. Distributors must therefore factor in transport and warehousing conditions. Another limitation is regulatory fragmentation: a nicotine film that is acceptable in one jurisdiction may require formula or label changes in another, which is why SENO includes pre-shipment compliance review and market-specific adjustment support in its process.

Future Outlook for Nicotine Film Distribution

As smoke-free policies expand and consumer preference shifts toward discreet, portable nicotine formats, oral thin films are likely to become a more standardized SKU in distributor portfolios. The market projection from USD 112.34 million in 2024 to USD 174.18 million by 2035 indicates steady, but not explosive, growth. Distributors that establish supply relationships now may be better positioned to benefit from the broader modern oral nicotine category growth projected for the coming decade.

SENO's production capacity—1,000,000 to 5,000,000 strips per month, with annual output of 12,000,000 to 50,000,000 strips—suggests that it is structured for repeat orders and scalable private label programs. For distributors, the key evaluation criteria will continue to be dosage consistency, compliance documentation, packaging integrity, and the ability to customize product without disrupting supply.

Contact and Partnership Information

Distributors and brand owners evaluating a nicotine film manufacturing partner can contact SENO directly. SENO operates under Xin Sino Technology (Shenzhen) Co., Ltd. and can be reached by email at seno.serve@outlook.com, by phone at +86 134-1745-8127, or via WhatsApp at +1 (626) 232-2952. Additional information is available at https://seno-online.com/.

Frequently Asked Questions

What is the minimum order quantity for SENO nicotine film?

The minimum order quantity is 100,000 to 300,000 strips per SKU.

Does SENO support OEM, ODM, and private label manufacturing?

Yes. SENO provides OEM, ODM, and private label manufacturing services with a monthly production capacity of 1,000,000 to 5,000,000 strips. Standard production lead time is 20–30 days, while OEM or custom orders require 30–45 days.

Which markets does SENO export to?

SENO exports to Europe, the United States, Canada, Australia, and the Middle East.

What after-sales support does SENO provide?

SENO's after-sales support includes technical support for product and compliance, marketing material support, fast response for quality or logistics issues, and long-term partnership support.

How does SENO ensure product quality and compliance?

SENO uses a GMP-oriented production process, raw material traceability, batch testing and data traceability, third-party laboratory verification, and pre-shipment compliance checks. Test methods are aligned with reference standards such as Health Canada T-502.

What specifications are available for SENO nicotine film?

SENO nicotine film is available in 2 mg, 4 mg, or 6 mg strengths, with customizable options. Dissolution time is 10–30 seconds, film size is approximately 20 mm × 30 mm, thickness is 50–100 microns, and shelf life is 24 months under cool and dry storage.